Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Jul 29, 2026 (2 months ago)

CLEAR EYES Maximum Itchy Eye Relief

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of assurance of sterility. The recall is due to potential contamination

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

CLEAR EYES Maximum Itchy Eye Relief, 0.5 fl oz (15 mL) per dropper bottle, Sterile, Dist. by Medtech Products Inc., Tarrytown, NY 10591, a Prestige Consumer Healthcare Company. NDC: 67172-999-01 UPC 6 78112 65920 3

Affected NDC 67172-0999-01

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Clear Eyes Maximum Itchy Eye Relief
Glycerin and Naphazoline Hydrochloride and Zinc Sulfate
NDC 67172-0999
GLYCERIN 2.5 mg/mL; NAPHAZOLINE HYDROCHLORIDE .12 mg/mL; ZINC SULFATE 2.5 mg/mL Liquid
Ophthalmic
Prestige Brands Holdings, Inc. OTC
Recalling firm
Prestige Brands Holdings
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0766-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other recalls by Prestige Brands Holdings

All 2026 recalls

Other sterility / contamination recalls from 2026

All sterility / contamination recalls